A Multicenter, Double-Blind, Randomized, Parallel-Group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Subjects With Partial Seizures
Latest Information Update: 24 Aug 2023
At a glance
- Drugs Lamotrigine (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 23 Jan 2018 Results assessing the effect of Age-Related Factors on the PK of Lamotrigine and Potential Implications for Dose Optimisation in patients data obtained from NCT00043875, NCT00144872, NCT00113165, NCT00104416, NCT00516139, NCT00264615 published in the Clinical Pharmacokinetics
- 15 Jun 2012 Additional location (South Korea) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Additional location identified as reported by ClinicalTrials.gov.